Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: Role of fractalkine/CX3CR1 signaling

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Briones, Teresita L ^a   Woods, Julie ^b   Wadowska, Magdalena ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cytokines; Learning and memory; Microglia; siRNA

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; INTERLEUKIN 1BETA; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL TEST; BRAIN ISCHEMIA; CELL ACTIVATION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; EXPERIMENTAL TEST; HIPPOCAMPUS; MALE; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WISTAR RAT; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; EXPERIMENTAL BEHAVIORAL TEST; MOLECULAR PATHOLOGY; TASK PERFORMANCE; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ANTIGENS, CD11B; CHEMOKINE CX3CL1; COGNITION DISORDERS; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCEINS; GENE EXPRESSION REGULATION; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; RATS; RATS, WISTAR; RECEPTORS, CHEMOKINE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84892648304     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-13     Document Type: Article

References (34)

1. McColl BW, Allan SM, Rothwell NJ. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem Soc Trans 2007, 35:1163-1165. 10.1042/BST0351163, 17956302.
2. Muir KW, Tyrrell PJ, Sattar N, Warburton EC. Inflammation and ischaemic stroke. Curr Opin Neurol 2007, 20:334-342. 10.1097/WCO.0b013e32813ba151, 17495630.
3. Selakovic V, Raicevic R, Radenovic L. Temporal patterns of souluble adhesion molecules in cerebrospinal fluid and plasma in patients with the acute brain infraction. Dis Markers 2009, 26:65-74. 10.1155/2009/490867, 3833413, 19407361.
4. Pluta R, Ulamek-Koziol M, Januszewski S, Scislewska M, Bogucka-Kocka A, Kocki J. Alzheimer's factors in postischemic dementia. Rom J Morphol Embryol 2012, 53:461-466.
5. Eggen BJL, Raj D, Hanisch UK, Boddeke HW. Microglial phenotype and adaptation. J Neuroimmune Pharmacol 2013, 8:807-823. 10.1007/s11481-013-9490-4, 23881706.
6. Neumann J, Sauerzweig S, Ronicke R, Gunzer F, Dinkel K, Ullrich O, Gunzer M, Reymann KG. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci 2008, 28:5965-5975. 10.1523/JNEUROSCI.0060-08.2008, 18524901.
7. Lalancette-Hebert M, Gowing G, Simard A, Weng YG, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605. 10.1523/JNEUROSCI.5360-06.2007, 17344397.
8. Harrison JK, Jiang Y, Chen SF, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998, 95:10896-10901. 10.1073/pnas.95.18.10896, 27992, 9724801.
9. Ransohoff RM, Liu L, Cardona AE. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 2007, 82:187-204.
10. Desforges NM, Hebron ML, Algarzae NK, Lonskaya I, Moussa CE. Fractalkine mediates communication between pathogenic proteins and microglia: implications of anti-inflammatory treatments in different stages of neurodegenerative diseases. Int J Alzheimers Dis 2012, 2012:345472. 3420133, 22919540.
11. Maggi L, Scianni M, Branchi I, D'Andrea I, Lauro C, Limatola C. CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front Cell Neurosci 2011, 5:22. 3198035, 22025910.
12. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006, 9:917-924. 10.1038/nn1715, 16732273.
13. Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J Neuroinflammation 2011, 8:9. 10.1186/1742-2094-8-9, 3039584, 21266082.
14. Cho S-H, Sun B, Zhou Y, Kauppinen TM, Halbisky B, Wes P, Ransohoff RM, Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 2011, 286:32713-32722. 10.1074/jbc.M111.254268, 3173153, 21771791.
15. Ladecola C, Anrather J. The immunology of stroke: from mechanims to translation. Nat Med 2011, 17:796-808. 10.1038/nm.2399, 3137275, 21738161.
16. Fumagalli S, Perego C, Ortolano F, De Simoni MG. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 2013, 61:827-842. 10.1002/glia.22474, 23440897.
17. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F, Limatola C. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 2011, 31:16327-16335. 10.1523/JNEUROSCI.3611-11.2011, 22072684.
18. Denes A, Ferenczi S, Halasz J, Kornyei Z, Kovacs K. Role of CX3CR1 (fractalkine receptor) in brain damage and neuroinflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 2008, 28:1707-1721. 10.1038/jcbfm.2008.64, 18575457.
19. Briones TL, Suh E, Jozsa L, Hattar H, Chai J, Wadowska M. Behaviorally-induced ultrastructural plasticity in the hippocampal region after cerebral ischemia. Brain Res 2004, 997:137-146. 10.1016/j.brainres.2003.10.030, 14706865.
20. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates 1997, London: Academic Press, 3.
21. Lourbopoulos A, Grigoriadis N, Karacostas D, Spandou E, Artemis N, Milonas I, Tascos N, Simeonidou C. Predictable ventricular shift after focal cerebral ischemia in rats: practical considerations for intraventricular therapeutic interventions. Lab Anim 2011, 44:71-78.
22. Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol Aging 2013, 34:2843-2852. 10.1016/j.neurobiolaging.2013.06.003, 23855980.
23. Sioud M. siRNA delivery in vivo. Methods Mol Biol 2005, 309:237-249.
24. Morris RG. Long-term potentiation and memory. Philos Trans R Soc Lond B Biol Sci 2003, 358:643-647. 10.1098/rstb.2002.1230, 1693171, 12740109.
25. Winocur G, Hasher L. Age and time-of-day effects on learning and memory in a non-matching-to-sample test. Neurobiol Aging 2004, 25:1107-1115. 10.1016/j.neurobiolaging.2003.10.005, 15212835.
26. Briones TL, Rogozinska M, Woods J. Modulation of ischemia-induced NMDAR1 activation by environmental enrichment decreases oxidative damage. J Neurotrauma 2011, 28:2485-2492. 10.1089/neu.2011.1842, 3235341, 21612313.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-â̂ †â̂ †CT method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
28. Hassani Z, Lemkine GF, Erbacher P, Palmier K, Alfama G, Behr C, Demeneix J-P. Lipid-mediated siRNA delivery downregulates exogenous gene expression in the mouse brain at picomolar levels. J Gene Med 2005, 7:198-207.
29. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 2002, 125:59-65. 10.1016/S0165-5728(02)00033-4, 11960641.
30. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. Expression of fractalkine and its receptor, CX3CR1, in response to ischemia-reperfusion brain injury in the rat. Eur J Neuroscie 2002, 15:1663-1668.
31. Weinstein JR, Koerner IP, Moller T. Microglia in ischemic brain injury. Future Neurol 2010, 5:227-246. 10.2217/fnl.10.1, 2853969, 20401171.
32. Gaikward SM, Heneka MT. Studying M1 and M2 states in adult microglia. Methods Mol Biol 2013, 1041:185-197. 10.1007/978-1-62703-520-0_18, 23813380.
33. Wang J, Yang Z, Liu CL, Zhao Y, Chen Y. Activated microglia provide a neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-alpha secretion after subacute cerebral ischemia. Int J Mol Med 2013, 31:172-178. 3573737, 23151666.
34. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 2011, 31:16241-16250. 10.1523/JNEUROSCI.3667-11.2011, 3236509, 22072675.